CIBC Private Wealth Group, LLC - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 229 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 2.02 and the average weighting 0.1%.

Quarter-by-quarter ownership
CIBC Private Wealth Group, LLC ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$1,036,000
-3.5%
12,0410.0%0.00%0.0%
Q2 2022$1,074,000
-20.7%
12,0410.0%0.00%0.0%
Q1 2022$1,355,000
-27.2%
12,041
-0.1%
0.00%
-25.0%
Q4 2021$1,862,000
+9.8%
12,058
-1.0%
0.00%0.0%
Q3 2021$1,696,000
-8.3%
12,174
-13.7%
0.00%0.0%
Q2 2021$1,850,000
-14.1%
14,103
-0.2%
0.00%
-20.0%
Q1 2021$2,154,000
+64.4%
14,133
+7.3%
0.01%
+66.7%
Q4 2020$1,310,000
-8.3%
13,169
-12.1%
0.00%
-25.0%
Q3 2020$1,429,000
-14.6%
14,989
+0.1%
0.00%
-50.0%
Q2 2020$1,674,000
+17.8%
14,967
-23.4%
0.01%
+33.3%
Q1 2020$1,421,000
-39.0%
19,538
-12.6%
0.01%
-25.0%
Q4 2019$2,331,000
-66.1%
22,360
-67.7%
0.01%
-66.7%
Q3 2019$6,883,000
-17.0%
69,153
-4.8%
0.02%
-17.2%
Q2 2019$8,295,000
-14.0%
72,676
-5.3%
0.03%
-21.6%
Q1 2019$9,647,000
+2.9%
76,734
+11.0%
0.04%
-11.9%
Q4 2018$9,377,000
-43.3%
69,100
+14.6%
0.04%
-33.3%
Q3 2018$16,544,000
+14.0%
60,277
-14.0%
0.06%
+6.8%
Q2 2018$14,512,000
-40.6%
70,052
-52.7%
0.06%
-44.3%
Q1 2018$24,441,000
+21.6%
147,985
+0.8%
0.11%
+24.7%
Q4 2017$20,106,000
+2.7%
146,832
+2.1%
0.08%
-4.5%
Q3 2017$19,585,000
+14.2%
143,839
+1.8%
0.09%
-17.6%
Q2 2017$17,154,000
+13.8%
141,299
-0.8%
0.11%
+13.7%
Q1 2017$15,071,000
+3.3%
142,393
-0.8%
0.10%
-1.0%
Q4 2016$14,587,000
-0.3%
143,571
+0.2%
0.10%
-5.0%
Q3 2016$14,627,000
-27.0%
143,324
-14.6%
0.10%
-30.8%
Q2 2016$20,024,000167,8850.15%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Knott David M Jr 115,000$12,937,0004.12%
Stonepine Capital Management, LLC 73,700$8,291,0003.44%
VILLERE ST DENIS J & CO LLC 510,843$57,464,0003.41%
Chicago Capital, LLC 491,717$55,313,0002.38%
Orchard Capital Management, LLC 73,596$8,279,0002.35%
RICE HALL JAMES & ASSOCIATES, LLC 344,969$38,806,0001.55%
Smith, Graham & Co., Investment Advisors, LP 86,834$9,768,0001.02%
WOODSTOCK CORP 64,050$7,205,0000.84%
INVESTMENT MANAGEMENT OF VIRGINIA LLC 37,246$4,190,0000.74%
Stephens Investment Management Group LLC 417,670$46,984,0000.69%
View complete list of LIGAND PHARMACEUTICALS INC shareholders